Multi-component signaling complexes of the δ-opioid receptor with STAT5B and G proteins

Neuropharmacology

Volumn 59, Issue 3, 2010, Pages 139-148

  Georganta, Eirini Maria ^a   Agalou, Adamantia ^a   Georgoussi, Zafiroula ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

Opioid receptor; G , G subunits; Signal Transducer and Activator of Transcription 5B; Signaling complex; Tyrosine phosphorylation

Indexed keywords

DELTA OPIATE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN KINASE P60; STAT5B PROTEIN; 4-AMINO-5-(4-METHYLPHENYL)-7-(TERT-BUTYL)PYRAZOLO(3,4-D)PYRIMIDINE; ENKEPHALIN, SER(2), LEU(5), THR(6)-; ENZYME INHIBITOR; LEUCINE ENKEPHALIN; MORPHINE; NARCOTIC ANALGESIC AGENT; PERTUSSIS TOXIN; PROTEIN BINDING; PROTEIN SUBUNIT; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE; STAT5 PROTEIN; STAT5B PROTEIN, HUMAN; TYROSINE;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; AMINO ACID SEQUENCE; ANALOGS AND DERIVATIVES; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; PHYSIOLOGY; PROCEDURES; PROTEIN SUBUNIT; PROTEIN TERTIARY STRUCTURE; TRANSFORMED CELL LINE;

AMINO ACID SEQUENCE; ANALGESICS, OPIOID; CELL LINE, TRANSFORMED; CONSERVED SEQUENCE; ENKEPHALIN, LEUCINE; ENZYME ACTIVATION; ENZYME INHIBITORS; GTP-BINDING PROTEINS; HUMANS; IMMUNOPRECIPITATION; MORPHINE; MUTATION; PERTUSSIS TOXIN; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN SUBUNITS; PYRAZOLES; PYRIMIDINES; RECEPTORS, OPIOID, DELTA; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TRANSFECTION; TYROSINE;

EID: 77954144156     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2010.04.010     Document Type: Article

References (40)

1. Archer-Lahlou E., Audet N., Amraei M.G., Huard K., Paquin-Gobeil M., Pineyro G. Src promotes delta-opioid receptor (DOR) desensitization by interfering with receptor recycling. J. Cell. Mol. Med. 2009, 13:147-163.
2. Bromberg K.D., Iyengar R., He J.C. Regulation of neurite outgrowth by G(i/o) signaling pathways. Front. Biosci. 2008, 13:4544-4557.
3. Cao X., Tay A., Guy G.R., Tan Y.H. Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol. Cell. Biol. 1996, 16:1595-1603.
4. Christie M.J. Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br. J. Pharmacol. 2008, 154:384-396.
5. Douris V., Swevers L., Labropoulou V., Andronopoulou E., Georgoussi Z., Iatrou K. Stably transformed insect cell lines: tools for expression of secreted and membrane-anchored proteins and high-throughput screening platforms for drug and insecticide discovery. Adv. Virus Res. 2006, 68:113-156.
6. Gentili C., Boland R., de Boland A.R. Implication of Gβγ proteins and c-Src tyrosine kinase in parathyroid hormone-induced signal transduction in rat enterocytes. J. Endocrinol. 2006, 188:69-78.
7. Georgoussi Z. Novel interacting partners regulating opioid receptor signaling. Molecular Aspects of G Protein-Coupled Receptors 2008, 169-206. Nova Science Publishers Inc. F. Ciruela, R. Lujan (Eds.).
8. Georgoussi Z., Carr C., Milligan G. Direct measurements of in situ interactions or rat brain opioid receptors with the guanine nucleotide binding protein Go. Mol. Pharmacol. 1993, 41:62-69.
9. Georgoussi Z., Leontiadis L., Mazarakou G., Merkouris M., Hyde K., Hamm H. Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the μ- and δ-opioid receptors regulate opioid receptor signalling. Cell. Signal. 2006, 18:771-782.
10. Georgoussi Z., Merkouris M., Mullaney I., Megaritis G., Carr C., Zioudrou C., Milligan G. Selective interactions of μ-opioid receptors with pertussis toxin-sensitive G proteins: involvement of the third intracellular loop and the C-terminal tail in coupling. Biochim. Biophys. Acta 1997, 1359:263-274.
11. Hauser K.F., Mangoura D. Diversity of the endogenous opioid system in development. Novel signal transduction translates multiple extracellular signals into neural cell growth and differentiation. Prospect. Dev. Neurobiol. 1998, 5:437-449.
12. Hong M.H., Xu C., Wang Y.J., Ji J.L., Tao Y.M., Xu X.J., Chen J., Xie X., Chi Z.Q., Liu J.G. Role of Src in ligand-specific regulation of δ-opioid receptor desensitization and internalization. J. Neurochem. 2009, 108:102-114.
13. Kazansky A.V., Kabotyanski E.B., Wyszomierski S.L., Manzini M.A., Rosen J.M. Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A.J. Biol. Chem. 1999, 274:22 484-22 492.
14. Kramer H.K., Onoprishvili I., Andria M.L., Hanna K., Sheinkman K., Haddad L.B., Simon E.J. Delta opioid activation of the mitogen-activated protein kinase cascade does not require transphosphorylation of receptor tyrosine kinases. BMC Pharmacol. 2002, 2:5-14.
15. Law P.Y., Wong Y.H., Loh H.H. Molecular mechanisms and regulation of opioid receptor signaling. Annu. Rev. Pharmacol. Toxicol. 2000, 40:389-430.
16. Leontiadis L.J., Papakonstantinou M.P., Georgoussi Z. Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate μ- and δ-opioid receptor signaling. Cell. Signal. 2009, 21:1218-1228.
17. Levy D.E., Darnell J.E. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell. Biol. 2002, 3:651-662.
18. Liang H., Venema V.J., Wang X., Ju H., Venema R.C., Marrero M.B. Regulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells. J. Biol. Chem. 1999, 274:19 846-19 851.
19. Lim C.P., Cao X. Structure, function, and regulation of STAT proteins. Mol. Biosyst. 2006, 2:536-550.
20. Lo R.K., Wong Y.H. Signal transducer and activator of transcription 3 activation by the δ-opioid receptor via Gα14 involves multiple intermediates. Mol. Pharmacol. 2004, 65:1427-1439.
21. Ma Y.C., Huang J., Ali S., Lowry W., Huang X.Y. Src tyrosine kinase is a novel effector of G protein. Cell 2000, 102:635-646.
22. Mazarakou G., Georgoussi Z. STAT5A interacts with and is phosphorylated upon activation of the μ-opioid receptor. J. Neurochem. 2005, 93:918-931.
23. McWhinney C.D., Dostal D., Baker K. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes. J. Mol. Cell. Cardiol. 1998, 30:751-761.
24. Megaritis G., Merkouris M., Georgoussi Z. Functional domains of delta- and mu-opioid receptors responsible for adenylyl cyclase inhibition. Recept. Channels 2000, 7:199-212.
25. Milligan G. Opioid receptors and their interacting proteins. Neuromolecular Med. 2005, 7:51-59.
26. Morou E., Georgoussi Z. Expression of the third intracellular loop of the δ-opioid receptor inhibits signaling by opioid receptors and other G protein-coupled receptors. J. Pharmacol. Exp. Ther. 2005, 315:1368-1379.
27. Nishimoto A., Yu Y., Lu Z., Mao X., Ren Z., Watowich S.S., Mills G.B., Liao W.S.L., Chen X., Bast R.C., Luo R.Z. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells. Cancer Res. 2005, 65:6701-6710.
28. Park E.S., Kim H., Suh J.M., Park S.J., You S.H., Chung H.K., Lee K.W., Kwon O.Y., Cho B.Y., Kim Y.K., Ro H.K., Chung J., Shong M. Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signaling pathway. Mol. Endocrinol. 2000, 14:662-670.
29. Pineyro G. Membrane signalling complexes: implications for development of functionally selective ligands modulating heptahelical receptor signalling. Cell. Signal. 2009, 21:179-185.
30. Ram P.T., Horvath C.M., Iyengar R. Stat3-mediated transformation of NIH-3T3 cells by the constitutively active Q205L Gao protein. Science 2000, 287:142-144.
31. Roy A.A., Lemberg K.E., Chidiac P. Recruitment of RGS2 and RGS4 to the plasma membrane by G proteins and receptors reflects functional interactions. Mol. Pharmacol. 2003, 64:587-593.
32. Sasaguri T., Teruya H., Ishida A., Abumiya T., Ogata J. Linkage between α1- adrenergic receptor and the Jak/STAT signaling pathway in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 2000, 268:25-30.
33. Simon A.R., Vikis H.G., Stewart S., Fanburg B.L., Cochran B.H., Guan K.L. Regulation of STAT3 by direct binding to the Rac1 GTPase. Science 2000, 290:144-147.
34. Smrcka A.V. G protein βγ subunits: central mediators of G protein-coupled receptor signaling. Cell. Mol. Life Sci. 2008, 65:2191-2214.
35. Spiegelberg B.D., Hamm H.E. Roles of G-protein-coupled receptor signaling in cancer biology and gene transcription. Curr. Opin. Genet. Dev. 2007, 17:40-44.
36. Tsai C.T., Lai L.P., Kuo K.T., Hwang J.J., Hsieh C.S., Hsu K.L., Tseng C.D., Tseng Y.Z., Chiang F.T., Lin J.L. Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling. Circulation 2008, 117:344-355.
37. Tso P.H., Wong Y.H. Molecular basis of opioid dependence: role of signal regulation by G-proteins. Clin. Exp. Pharmacol. Physiol. 2003, 30:307-316.
38. Whistler J.L., Chiang H., Chu P., Jan L.Y., Zastrow M. Functional dissociation of μ-opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 1999, 23:737-746.
39. Willard F.S., Crouch M.F. Nuclear and cytoskeletal translocation and localization of heterotrimeric G-proteins. Immunol. Cell Biol. 2000, 78:387-394.
40. Wu E.H., Lo R.K., Wong Y.H. Regulation of STAT3 activity by G16-coupled receptors. Biochem. Biophys. Res. Commun. 2003, 303:920-925.